Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Assessment and management of the consequences of stroke. In: Clinical guidelines for acute stroke management.

BIBLIOGRAPHIC SOURCE(S)

  • Assessment and management of the consequences of stroke. In: National Stroke Foundation. Clinical guidelines for acute stroke management. Melbourne (Australia): National Stroke Foundation; 2007 Oct. p. 30-8.

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The levels of evidence supporting the recommendations (I-IV) and grades of recommendations (A-D and clinical practice points [CPP]) are defined at the end of the "Major Recommendations" field.

The original guideline document also includes a consumer rating that identifies aspects of care considered to be critical from a patient perspective.

Dysphagia

Patients should be screened for swallowing deficits before being given food, drink or oral medications. Screening should be undertaken by personnel specifically trained in swallowing screening. (Grade C, Level I [Perry & Love, 2001; Martino, Pron, & Diamant, 2000])

Patients should be screened within 24 hours of admission. (CPP)

Patients who fail the swallowing screening should be referred to a speech pathologist for a comprehensive assessment. (CPP)

Nutrition

Close monitoring of hydration status and appropriate fluid supplementation should be used to treat or prevent dehydration. (Grade B; Level I [Hodgkinson, Evans, & Wood, 2003])

All patients with acute stroke should be screened for malnutrition. (Grade B; Level II [Dennis et al., "Routine oral nutritional," 2005])

Those who are at risk of malnutrition, including those with dysphagia, should be referred to a dietitian for assessment and ongoing management. Assessment of nutritional status should include the use of validated nutrition assessment tools or measures. (CPP)

Nutritional supplementation should be offered to people whose nutritional status is poor or deteriorating. (Grade A; Level I [Milne, Avenell, & Potter, 2006])

Nasogastric (NG) feeding is the preferred method during the first month post stroke for people who do not recover a functional swallow. (Grade B; Level II [Dennis et al., "Effect of the timing and method," 2005])

Food intake should be monitored for all people with acute stroke. (CPP)

Early Mobilisation

Patients should be mobilised as early and as frequently as possible. (Grade B; Level II [Indredavik et al., 1999])

After assessment the physiotherapist should advise staff and carers of appropriate mobilising and transfer techniques. (CPP)

Early Therapy for Difficulties with Activities of Daily Living (ADL)

Patients with difficulties in occupational performance in daily activities should be treated by an occupational therapist or a specialist multidisciplinary team that includes an occupational therapist. (Grade B; Level I [Langhorne et al., 2002; Legg, Drummond, & Langhorne, 2006])

Patients with confirmed difficulties in occupational performance in personal tasks, instrumental activities, vocational activities or leisure activities should have a management plan formulated and documented to address these issues. (CPP)

The occupational therapist should advise staff and carers on techniques and equipment to maximise outcomes relating to functional performance in daily activities, sensorimotor, perceptual and cognitive capacities. (CPP)

Cognition and Perception

All patients should be screened for cognitive and perceptual deficits using a validated screening tool. (CPP)

Patients identified during screening should undertake full assessment and management by an appropriately trained health professional. (CPP)

Communication

All patients should be screened for communication deficits using a validated screening tool. (Grade C, Level I [Salter et al., 2006)])

Those with suspected communication difficulties should receive formal assessment by a speech pathologist. (CPP)

Patients with communication difficulties should be treated as early and as frequently as possible. (Grade C, Level I [Bhogal, Teasell, & Speechley, 2003] & Level III-2 [Robey, 1998])

All written health information should be available in an aphasia friendly format. (Grade D, Level IV [Rose, Worrall, & McKenna, 2003])

The speech pathologist should advise staff and family/carers of appropriate communication techniques. (Grade C, Level II [Kagan et al., 2001; Wertz et al., 1986])

Incontinence

All patients with suspected continence difficulties should be assessed by trained personnel using a structured functional assessment. (Grade B; Level II [Thomas et al., 2005])

A portable bladder ultrasound scan can be used to assist in diagnosis and management of urinary incontinence. (Grade B; Level I [Martin et al., 2006]).

Patients with confirmed continence difficulties should have a continence management plan formulated and documented. (Grade C; Level II [Thomas et al., 2005])

The use of indwelling catheters should be avoided as an initial management strategy. (CPP)

A post discharge continence management plan should be developed with the patient and carer prior to discharge and should include how to access continence resources in the community. (CPP)

Mood

Patients with suspected altered mood (e.g., depression, anxiety, emotional lability) should be assessed by trained personnel using a standardised scale. (Grade B; Level II & Level III-1 [Joubert et al., 2006; Aben et al., 2002; Lincoln et al., 2003; Williams et al., 2005; Benaim et al., 2004; Watkins et al., 2007])

Patients with stroke may be managed using a case management model after discharge to reduce post stroke depression. If used, services should incorporate education of the recognition and management of depression, screening and assistance to coordinate appropriate interventions via a medical practitioner. (Grade C; Level II [Joubert et al., 2006; Williams et al., 2007])

Routine use of antidepressants to prevent poststroke depression is not currently recommended. (Grade B; Level I [Anderson, Hackett, & House, 2004])

Antidepressants may be used for people with emotional lability. (Grade B; Level I [House et al., 2004])

Patients with depression or anxiety may be treated with antidepressants and/or psychological interventions to improve mood. (Grade B; Level I [Hackett, Anderson, & House, 2004])

Definitions:

Levels of Evidence

Level Intervention Diagnosis Prognosis Aetiology Screening
I A systematic review of Level II studies A systematic review of Level II studies A systematic review of Level II studies A systematic review of Level II studies A systematic review of Level II studies
II A randomised controlled trial A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation A prospective cohort study A prospective cohort study A randomised controlled trial
III-1 A pseudo-randomised controlled trial (i.e., alternate allocation or some other method) A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation All or none All or none A pseudo-randomised controlled trial (i.e., alternate allocation or some other method)
III-2 A comparative study with concurrent controls:
  • Non-randomised experimental trial
  • Cohort study
  • Case-control study
  • Interrupted time series without a parallel control group
A comparison with a reference standard that does not meet the criteria required for Level II and Level III-1 evidence Analysis of prognostic factors amongst untreated control patients in a randomised controlled trial A retrospective cohort study A comparative study with concurrent controls:
  • Nonrandomised, experimental trial
  • Cohort study
  • Case-control study
III-3 A comparative study without concurrent controls:
  • Historical control study
  • Two or more single arm study
  • Interrupted time series without a parallel control group
Diagnostic case-control study A retrospective cohort study A case-control study A comparative study without concurrent controls:
  • Historical control study
  • Two or more single arm study
IV Case series with either post-test or pre-test/post-test outcomes Study of diagnostic yield (no reference standard) Case series or cohort study of patients at different stages of disease A cross-sectional study Case series

Grading of Recommendations

Grade Description
A Body of evidence can be trusted to guide practice
B Body of evidence can be trusted to guide practice in most situations
C Body of evidence provides some support for recommendation(s) but care should be taken in its application
D Body of evidence is weak and recommendation must be applied with caution
Clinical Practice Points
CPP Recommended best practice based on clinical experience and expert opinion

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Assessment and management of the consequences of stroke. In: National Stroke Foundation. Clinical guidelines for acute stroke management. Melbourne (Australia): National Stroke Foundation; 2007 Oct. p. 30-8.

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2007 Oct

GUIDELINE DEVELOPER(S)

National Stroke Foundation (Australia) - Private Nonprofit Organization

SOURCE(S) OF FUNDING

Australian Government Department of Health and Ageing

GUIDELINE COMMITTEE

Expert Working Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Group Members: Dr Alan Barber, Neurologist, Auckland City Hospital; Dr Christopher Beer, Senior Lecturer, University of Western Australia and Geriatrician/Clinical Pharmacologist Royal Perth and Mercy Hospitals and Swan Health Service; Prof Justin Beilby, Executive Dean, Faculty of Health Sciences and Professor of General Practice, University of Adelaide; Assoc Prof Julie Bernhardt, Physiotherapist, National Stroke Research Institute; Prof Christopher Bladin, Neurologist, Box Hill Hospital; Ms Brenda Booth, Consumer, Working Aged Group with Stroke, NSW; Dr Julie Cichero, Speech Pathologist, Private Practice & University of Queensland; Ms Louise Corben, Occupational Therapy, Monash Medical Centre & Bruce Lefroy Centre Murdoch Children's Research Institute; Dr Denis Crimmins (Chair) Neurologist, Gosford Hospital; Dr Richard Gerraty, Neurologist, Alfred Hospital and Monash University; Mr Kelvin Hill, Manager, Guidelines Program, National Stroke Foundation; Dr Erin Lalor, Chief Executive Officer, National Stroke Foundation; Assoc Prof Christopher Levi, Neurologist, John Hunter Hospital; Prof Richard Lindley, Professor of Geriatric Medicine, University of Sydney and Westmead Hospital; Prof Sandy Middleton, School of Nursing (NSW & ACT), Australian Catholic University; Ms Fiona Simpson, Dietitian and Senior Research Fellow, Royal North Shore Hospital Sydney

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

All members of the working group completed and signed a declaration of potential conflicts of interest with development of these guidelines. Most had no perceived conflicts. The reasons provided for potential conflicts primarily involved receiving money from non commercial and commercial organisations specifically for undertaking clinical research. This was expected given the expertise of members of the working group in clinical research. Only a small number of members had received financial support from commercial companies for providing consultancy or lecturing.

ENDORSER(S)

Australian and New Zealand Society for Geriatric Medicine - Medical Specialty Society
Australian College of Rural and Remote Medicine - Professional Association
Australian Physiotherapy Association - Medical Specialty Society
BeyondBlue: The National Depression Initiative - National Government Agency [Non-U.S.]
Council of Ambulance Authorities (Australia) - Professional Association
Dietitians Association of Australia - Professional Association
Occupational Therapy Australia - Professional Association
Royal Australian and New Zealand College of Radiologists - Professional Association
Speech Pathology Australia - Medical Specialty Society
Stroke Society of Australasia - Disease Specific Society

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the National Stroke Foundation (Australia) Web site.

Print copies: Available from the National Stroke Foundation (Australia), Level 7, 461 Bourke Street, Melbourne Victoria 3000, Australia.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

The following are available:

  • Early testing and treatment. Melbourne (Australia): National Stroke Foundation; 2005. 16 p.
  • Stroke rehabilitation. Melbourne (Australia): National Stroke Foundation; 2005. 19 p.
  • Long term recovery. Melbourne (Australia): National Stroke Foundation; 2005. 16 p.

Electronic copies: Available in Portable Document Format (PDF) from the National Stroke Foundation (Australia) Web site.

Print copies: Available from the National Stroke Foundation (Australia), Level 7, 461 Bourke Street, Melbourne Victoria 3000, Australia.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI Institute on November 26, 2008. The information was verified by the guideline developer on December 4, 2008.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo